InvestorsHub Logo
icon url

Spumoni

06/25/19 10:10 AM

#432 RE: DewDiligence #431

So what do ABBV shareholders get?
icon url

jdlamont

06/25/19 11:26 AM

#437 RE: DewDiligence #431

next is eyen! what a bargain
icon url

DewDiligence

11/13/19 10:26 AM

#510 RE: DewDiligence #431

ABBV sells $30B of bonds to fund AGN acquisition: #msg-152249872.
icon url

DewDiligence

01/08/20 10:08 AM

#515 RE: DewDiligence #431

ABBV names executive to oversee AGN’s medical aesthetics business following merger:

https://finance.yahoo.com/news/abbvie-announces-leadership-team-creation-130000368.html
icon url

DewDiligence

03/03/20 9:31 AM

#533 RE: DewDiligence #431

ABBV-AGN receive EU approval for merger—US FTC approval still pending:

https://finance.yahoo.com/news/abbvie-allergan-receive-final-european-130000384.html
icon url

DewDiligence

05/06/20 12:48 PM

#563 RE: DewDiligence #431

icon url

DewDiligence

05/08/20 4:56 PM

#566 RE: DewDiligence #431

ABBV completes $65B AGN acquisition:

https://www.allergan.com/News/Details/2020/05/AbbVie%20Inc%20Completes%20Acquisition%20of%20Allergan%20plc

The deal, announced in Jun 2019 (#msg-149577810), entitles each AGN share to receive 0.886 shares of ABBV plus $120.30 in cash, a nominal value of $194.69/sh (3% higher than the nominal value of $188.24/sh nominal value at the time of the deal announcement).